http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021145810-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9f9acf1f09543e6f0d89828a09b4424c |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-46 |
| filingDate | 2020-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac6274ce9ec3ed553cca9d4f6496f67a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_151c83ffcd7708e08306c0c22d17c018 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09131d9a0b7ed2704e70cf97740d53bb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efba63eff940120bc0bd8989a3d705fb |
| publicationDate | 2021-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2021145810-A1 |
| titleOfInvention | Xanomeline derivatives and methods for treating neurological disorders |
| abstract | Provided herein are compounds comprising compounds of formula I n n n n n n n n n n and/or salts thereof;n nwherein at least one of R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , R 12 , and R 13 is fluorine, and the remainder are independently chosen from hydrogen and fluorine; and R 14 , R 15 , R 16 , R 17 , R 18 , R 19 , R 20 , R 21 , R 22 , and R 23 are independently chosen from hydrogen and deuterium; with the proviso that when R 1 , R 2 , and R 3 are fluorine, then at least one of R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , R 12 , and R 13 is fluorine or at least one of R 14 , R 15 , R 16 , R 17 , R 18 , R 19 , R 20 , R 21 , R 22 , and R 23 is deuterium. Also provided are medicaments comprising these compounds and methods for treating central nervous system disorders with the compounds and medicaments described herein. |
| priorityDate | 2019-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1260.